APTINYX INC's ticker is APTX and the CUSIP is 03836N103. A total of 44 filers reported holding APTINYX INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $13 | – | 110 | 0.0% | 0.00% | – |
Q4 2022 | $0 | -100.0% | 110 | -89.0% | 0.00% | – |
Q2 2022 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | -33.3% | 1,000 | 0.0% | 0.00% | – |
Q4 2021 | $3,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2021 | $2,000 | -33.3% | 1,000 | 0.0% | 0.00% | – |
Q2 2021 | $3,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2021 | $3,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2020 | $3,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2020 | $3,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2020 | $4,000 | +100.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2020 | $2,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 3,290,079 | $1,836,000 | 1.19% |
ADAMS STREET PARTNERS LLC | 5,395,996 | $3,010,000 | 0.78% |
Bain Capital Life Sciences Investors, LLC | 8,891,758 | $4,961,000 | 0.58% |
Artal Group S.A. | 6,116,493 | $3,412,000 | 0.18% |
Frazier Life Sciences Management, L.P. | 1,883,244 | $1,051,000 | 0.10% |
NORTHWESTERN UNIVERSITY | 109,280 | $61,000 | 0.06% |
DCF Advisers, LLC | 48,529 | $27,000 | 0.02% |
Meridian Wealth Management, LLC | 192,000 | $107,000 | 0.01% |
Orbimed Advisors | 538,500 | $300,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 157,641 | $88,000 | 0.00% |